Alpha 2.0
Login Register
» Articles » PMID: 15173257

Improved Biomarkers for Prostate Cancer: a Definite Need

Overview
Journal J Natl Cancer Inst
Publisher Oxford University Press
Specialty Oncology
Date 2004 Jun 3
PMID 15173257
Citations 10
Authors
H Ballentine Carter
William B Isaacs
Affiliations
Soon will be listed here.
Citing Articles

Validation of a 10-gene molecular signature for predicting biochemical recurrence and clinical metastasis in localized prostate cancer.

Abou-Ouf H, Alshalalfa M, Takhar M, Erho N, Donnelly B, Davicioni E J Cancer Res Clin Oncol. 2018; 144(5):883-891.

PMID: 29511883 DOI: 10.1007/s00432-018-2615-7.

New serum biomarkers for prostate cancer diagnosis.

Chadha K, Miller A, Nair B, Schwartz S, Trump D, Underwood W Clin Cancer Investig J. 2015; 3(1):72-79.

PMID: 25593898 PMC: 4292911. DOI: 10.4103/2278-0513.125802.

Current early diagnostic biomarkers of prostate cancer.

Qu M, Ren S, Sun Y Asian J Androl. 2014; 16(4):549-54.

PMID: 24830695 PMC: 4104079. DOI: 10.4103/1008-682X.129211.

The expressions of AMACR and iNOS in prostate adenocarcinomas.

Ozgur T, Atik E, Hakverdi S, Yaldiz M Pak J Med Sci. 2013; 29(2):610-3.

PMID: 24353588 PMC: 3809268.

Quality of physician-patient relationships is associated with the influence of physician treatment recommendations among patients with prostate cancer who chose active surveillance.

Orom H, Homish D, Homish G, Underwood 3rd W Urol Oncol. 2013; 32(4):396-402.

PMID: 24332649 PMC: 4004652. DOI: 10.1016/j.urolonc.2013.09.018.